Search results
Results from the WOW.Com Content Network
NAOSH Week serves as an important reminder of the significance of workplace safety and health and offers an opportunity for employers, employees, and safety professionals to come together to promote these values. Before NAOSH Week, ASSP holds a children's "safety-on-the-job" poster contest to teach children about the significance of workplace ...
World Patient Safety Day was established in May 2019 when the 72nd World Health Assembly adopted resolution WHA 72.6 on ‘Global action on patient safety’. [6] This global campaign builds on a series of annual Global Ministerial Summits on Patient Safety initiated in 2016, as well as the high-level advocacy and commitment of major ...
World Day for Safety and Health at Work is a UN international day that is celebrated every April 28. It is concerned about safe work and awareness of the dimensions and consequences of work-related accidents and diseases; to place occupational safety and health (OSH) on the international and national agendas; and to provide support to the national efforts for the improvement of national OSH ...
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
The selection and use of essential medicines: report of the WHO Expert Committee, 2017 (including the 20th WHO Model List of Essential Medicines and the 6th Model List of Essential Medicines for Children). Geneva: World Health Organization. 2017. hdl: 10665/259481. ISBN 978-92-4-121015-7. ISSN 0512-3054. WHO technical report series; no. 1006.
Upgrade to a faster, more secure version of a supported browser. It's free and it only takes a few moments:
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Walter G. Campbell, one of the pioneers in the regulations of drug safety, launched the legal process against spurious drugs and took the stewardship in Food and Drug Administration (FDA) in 1940. [1] In 1950, a ruling in the U.S. Court of Appeals indicated the requirement of listing drug indication in drug labels.